The role of microglial cells in neurodegenerative disease is not fully understood. But new results from researchers in Munich and Basel suggest that stimulation of this arm of the immune system might well delay the onset of such disorders.
Gernot Kleinberger et al. The FTD‐like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism, The EMBO Journal (2017). DOI: 10.15252/embj.201796516
A minimal change in the TREM2 gene results in a marked reduction in the phagocytic activity of microglial cells in the brain of mutant mice (green, on the right) relative to the control (yellow and red, on the left). Source: Haass Lab. Credit: Ludwig Maximilian University of Munich











